Prime Medicine, Inc. (PRME) Stock Research

Prime Medicine, Inc.

· PRME

Dashboard

Financials

Ratios

Valuation

Statistics

560.454 M

-1.13%

Thursday

Closing Bell Movers: Akamai soars over 20% on Anthropic deal

+10

Sep 24, 7:27 PM

Prime Medicine announces FDA clearance of IND application for PM647

PRME

Sep 24, 4:02 PM

Over a week ago

Prime Medicine transferred with Buy rating at Chardan

PRME

Aug 25, 4:20 AM

BMO starts Prime Medicine at Outperform into 2027 readouts

PRME

Aug 18, 4:31 PM

Prime Medicine initiated with bullish view at BMO Capital, here's why

PRME

Aug 18, 4:21 PM

Prime Medicine reports Q4 EPS (24c), consensus (26c)

PRME

Aug 6, 9:16 AM

What You Missed On Wall Street On Wednesday

+31

Jul 8, 4:24 PM

TD Cowen says arbitration decision removes overhang for Prime Medicine's PM647

Jul 8, 12:41 PM

Midday Fly By: U.S. strikes targets in Iran, Trump says ceasefire 'over'

+31

Jul 8, 11:51 AM

Resolution in favor of Prime has limited impact to Beam, says BofA

Jul 8, 11:40 AM

Prime Medicine reports positive resolution to arbitration with Beam Therapeutics

Jul 8, 11:36 AM

Cathie Wood's ARK Investment buys 206.2K shares of Prime Medicine today

PRME

Jul 7, 8:12 PM

Prime Medicine just upgraded at H.C. Wainwright, here's why

PRME

Jun 29, 6:02 AM

Prime Medicine granted RMAT designation for PM359

PRME

Jun 22, 8:15 AM

Prime Medicine announces New Zealand cleared trial application for PM577a

PRME

Jun 18, 8:09 AM

Prime Medicine reports Q1 EPS (28c), consensus (25c)

PRME

May 7, 9:04 AM

Prime Medicine management to meet with Oppenheimer

PRME

May 6, 3:39 PM

Prime Medicine appoints Makhni as Chief Financial Officer

PRME

Apr 16, 8:12 AM

Oppenheimer bullish on Prime Medicine, initiates with an Outperform

PRME

Mar 12, 7:41 AM

Prime Medicine initiated with bullish view at Oppenheimer

PRME

Mar 12, 6:20 AM

Largest borrow rate increases among liquid names

Mar 4, 8:45 AM

Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year

PRME

Mar 3, 8:02 AM

Prime Medicine initiated with bullish view at LifeSci Capital, here's why

PRME

Dec 23, 8:47 AM

Prime Medicine announces NEJM publication of PM359 data

PRME

Dec 7, 1:29 PM

Charts